Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes
- PMID: 27620487
- DOI: 10.1016/j.bbalip.2016.09.004
Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes
Abstract
Impaired cardiac metabolism in the obese and diabetic heart leads to glucolipotoxicity and ensuing cardiomyopathy. Glucolipotoxicity causes cardiomyocyte injury by increasing energy insufficiency, impairing proteasomal-mediated protein degradation and inducing apoptosis. Proteasome-evading proteins are degraded by autophagy in the lysosome, whose metabolism and function are regulated by master regulator transcription factor EB (TFEB). Limited studies have examined the impact of glucolipotoxicity on intra-lysosomal signaling proteins and their regulators. By utilizing a mouse model of diet-induced obesity, type-1 diabetes (Akita) and ex-vivo model of glucolipotoxicity (H9C2 cells and NRCM, neonatal rat cardiomyocyte), we examined whether glucolipotoxicity negatively targets TFEB and lysosomal proteins to dysregulate autophagy and cause cardiac injury. Despite differential effects of obesity and diabetes on LC3B-II, expression of proteins facilitating autophagosomal clearance such as TFEB, LAMP-2A, Hsc70 and Hsp90 were decreased in the obese and diabetic heart. In-vivo data was recapitulated in H9C2 and NRCM cells, which exhibited impaired autophagic flux and reduced TFEB content when exposed to a glucolipotoxic milieu. Notably, overloading myocytes with a saturated fatty acid (palmitate) but not an unsaturated fatty acid (oleate) depleted cellular TFEB and suppressed autophagy, suggesting a fatty acid specific regulation of TFEB and autophagy in the cardiomyocyte. The effect of glucolipotoxicity to reduce TFEB content was also confirmed in heart tissue from patients with Class-I obesity. Therefore, during glucolipotoxicity, suppression of lysosomal autophagy was associated with reduced lysosomal content, decreased cathepsin-B activity and diminished cellular TFEB content likely rendering myocytes susceptible to cardiac injury.
Keywords: Cardiomyopathy; Glucolipotoxicity; LAMP-2A; Lysosomal autophagy; Obesity and diabetes; TFEB.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
TFEB Biology and Agonists at a Glance.Cells. 2021 Feb 5;10(2):333. doi: 10.3390/cells10020333. Cells. 2021. PMID: 33562649 Free PMC article. Review.
-
Loss of function of transcription factor EB remodels lipid metabolism and cell death pathways in the cardiomyocyte.Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165832. doi: 10.1016/j.bbadis.2020.165832. Epub 2020 May 8. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32437957
-
TFEB activation protects against cardiac proteotoxicity via increasing autophagic flux.J Mol Cell Cardiol. 2017 Dec;113:51-62. doi: 10.1016/j.yjmcc.2017.10.003. Epub 2017 Oct 7. J Mol Cell Cardiol. 2017. PMID: 28993153 Free PMC article.
-
Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy.Biochem J. 2016 Nov 1;473(21):3769-3789. doi: 10.1042/BCJ20160385. Epub 2016 Aug 3. Biochem J. 2016. PMID: 27487838
-
TFEB at a glance.J Cell Sci. 2016 Jul 1;129(13):2475-81. doi: 10.1242/jcs.146365. Epub 2016 Jun 1. J Cell Sci. 2016. PMID: 27252382 Free PMC article. Review.
Cited by
-
Transcriptional regulation of autophagy and its implications in human disease.Cell Death Differ. 2023 Jun;30(6):1416-1429. doi: 10.1038/s41418-023-01162-9. Epub 2023 Apr 12. Cell Death Differ. 2023. PMID: 37045910 Free PMC article. Review.
-
Biological functions of CRTC2 and its role in metabolism-related diseases.J Cell Commun Signal. 2023 Sep;17(3):495-506. doi: 10.1007/s12079-023-00730-5. Epub 2023 Mar 1. J Cell Commun Signal. 2023. PMID: 36856929 Free PMC article. Review.
-
Lysosomal dysfunction in diabetic cardiomyopathy.Front Aging. 2023 Jan 20;4:1113200. doi: 10.3389/fragi.2023.1113200. eCollection 2023. Front Aging. 2023. PMID: 36742461 Free PMC article. Review.
-
Experimental diabetes exacerbates autophagic flux impairment during myocardial I/R injury through calpain-mediated cleavage of Atg5/LAMP2.J Cell Mol Med. 2023 Jan;27(2):232-245. doi: 10.1111/jcmm.17642. Epub 2022 Dec 23. J Cell Mol Med. 2023. PMID: 36562207 Free PMC article.
-
Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice.Signal Transduct Target Ther. 2022 Aug 1;7(1):259. doi: 10.1038/s41392-022-01054-3. Signal Transduct Target Ther. 2022. PMID: 35909160 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous